Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Revenue

Qingdao Haier Biomedical Co.,Ltd had revenue of 652.08M CNY in the quarter ending March 31, 2026, a decrease of -5.36%. This brings the company's revenue in the last twelve months to 2.29B, up 0.26% year-over-year. In the year 2025, Qingdao Haier Biomedical Co.,Ltd had annual revenue of 2.33B with 1.96% growth.

• Revenue (ttm): 2.29B
• Revenue Growth: +0.26%
• P/S Ratio: 4.54
• Revenue / Employee: 778.19K
• Employees: 2,945
• Market Cap: 10.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.33B	44.84M	1.96%
Dec 31, 2024	2.28B	2.94M	0.13%
Dec 31, 2023	2.28B	-583.15M	-20.36%
Dec 31, 2022	2.86B	738.18M	34.72%
Dec 31, 2021	2.13B	723.83M	51.63%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error